Sofia Guay

Executive Director, Revenue Development at The Leukemia & Lymphoma Society of Canada

Sofia Guay has extensive experience in fundraising and strategic revenue development, particularly with The Leukemia & Lymphoma Society of Canada, where Sofia has held various leadership roles since April 2013, including Business Unit Director and Senior National Director, Strategic Revenue Development. In these positions, Sofia has provided national strategic leadership for fundraising campaigns, notably the Light the Night walk. Prior to these roles, Sofia served as Deputy Executive Director for Quebec & Atlantic Canada Regions and played a pivotal role in developing the Light the Night campaign in Montreal, Quebec, and Halifax, significantly increasing revenue and recognition. Earlier experience includes managing international production projects at Deluxe Digital Studios. Sofia's academic background includes degrees from McGill University and Ryerson University, focusing on translation and journalism.

Location

Gatineau, Canada

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices


The Leukemia & Lymphoma Society of Canada

The Leukemia & Lymphoma Society of Canada (LLSC) is a voluntary health agency dedicated to blood cancer. LLSC funds lifesaving blood cancer research across Canada and worldwide, and provides free information and support services. We won’t stop until there is a cure for leukemia, lymphoma, myeloma, myelodysplastic syndromes and myeloproliferative neoplasms and are able to improve the quality of life of people affected by blood cancers and their families by funding life-enhancing research and providing educational resources, services and support. Our strategy to achieve the mission is based on three areas of focus: research, patient support and advocacy. In 2017, we invested almost $7.4 million in the creation of programs and delivery of services to improve the lives of Canadians affected by blood cancers from coast to coast. This investment included a commitment of over $4.1 million in innovative, life-changing research to accelerate new cancer treatments, therapies, and cures; and $3.3 million towards funding patient services, programs and education across Canada. Everything we do is made possible through the generosity of individuals, corporate partners, and foundations. In the last two decades alone, the Leukemia & Lymphoma Society of Canada has raised $207 million for research and services. We receive no government support.


Industries

Headquarters

Toronto, Canada

Employees

51-200

Links